Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

357 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Smoking abstinence 1 year after acute coronary syndrome: follow-up from a randomized controlled trial of varenicline in patients admitted to hospital.
Windle SB, Dehghani P, Roy N, Old W, Grondin FR, Bata I, Iskander A, Lauzon C, Srivastava N, Clarke A, Cassavar D, Dion D, Haught H, Mehta SR, Baril JF, Lambert C, Madan M, Abramson BL, Eisenberg MJ; EVITA Investigators. Windle SB, et al. Among authors: madan m. CMAJ. 2018 Mar 26;190(12):E347-E354. doi: 10.1503/cmaj.170377. CMAJ. 2018. PMID: 29581161 Free PMC article. Clinical Trial.
Radial Versus Femoral Access for Coronary Angiography/Intervention in Women With Acute Coronary Syndromes: Insights From the RIVAL Trial (Radial Vs femorAL access for coronary intervention).
Pandie S, Mehta SR, Cantor WJ, Cheema AN, Gao P, Madan M, Niemela K, Rao SV, Schwalm JD, Valentin V, Velianou JL, Jolly SS. Pandie S, et al. Among authors: madan m. JACC Cardiovasc Interv. 2015 Apr 20;8(4):505-12. doi: 10.1016/j.jcin.2014.11.017. JACC Cardiovasc Interv. 2015. PMID: 25907080 Free article. Clinical Trial.
A randomized controlled trial of the efficacy and safety of varenicline for smoking cessation after acute coronary syndrome: design and methods of the Evaluation of Varenicline in Smoking Cessation for Patients Post-Acute Coronary Syndrome trial.
Windle SB, Bata I, Madan M, Abramson BL, Eisenberg MJ. Windle SB, et al. Among authors: madan m. Am Heart J. 2015 Oct;170(4):635-640.e1. doi: 10.1016/j.ahj.2015.07.010. Epub 2015 Jul 17. Am Heart J. 2015. PMID: 26386786 Clinical Trial.
Varenicline for Smoking Cessation in Hospitalized Patients With Acute Coronary Syndrome.
Eisenberg MJ, Windle SB, Roy N, Old W, Grondin FR, Bata I, Iskander A, Lauzon C, Srivastava N, Clarke A, Cassavar D, Dion D, Haught H, Mehta SR, Baril JF, Lambert C, Madan M, Abramson BL, Dehghani P; EVITA Investigators. Eisenberg MJ, et al. Among authors: madan m. Circulation. 2016 Jan 5;133(1):21-30. doi: 10.1161/CIRCULATIONAHA.115.019634. Epub 2015 Nov 9. Circulation. 2016. PMID: 26553744 Clinical Trial.
Smokers and Postcessation Weight Gain After Acute Coronary Syndrome.
Dehghani P, Habib B, Windle SB, Roy N, Old W, Grondin FR, Bata I, Iskander A, Lauzon C, Srivastava N, Clarke A, Cassavar D, Dion D, Haught H, Mehta SR, Baril JF, Lambert C, Madan M, Abramson BL, Eisenberg MJ. Dehghani P, et al. Among authors: madan m. J Am Heart Assoc. 2017 Apr 18;6(4):e004785. doi: 10.1161/JAHA.116.004785. J Am Heart Assoc. 2017. PMID: 28420644 Free PMC article. Clinical Trial.
Contemporary use of guideline-based higher potency P2Y12 receptor inhibitor therapy in patients with moderate-to-high risk non-ST-segment elevation myocardial infarction: Results from the Canadian ACS reflective II cross-sectional study.
Patel A, Goodman SG, Tan M, Suskin N, McKelvie R, Mathew AL, Lutchmedial S, Dehghani P, Lavoie AJ, Huynh T, Lavi S, Philipp R, Khan R, Yan AT, Radhakrishnan S, Sedlak T, Brunner N, Kim HH, Cieza T, Kassam S, Fordyce CB, Heffernan M, Jedrzkiewicz S, Madan M, Ahmed S, Barry C, Dery JP, Bagai A; Canadian ACS Reflective II Investigators. Patel A, et al. Among authors: madan m. Clin Cardiol. 2021 Jun;44(6):839-847. doi: 10.1002/clc.23618. Epub 2021 May 13. Clin Cardiol. 2021. PMID: 33982795 Free PMC article.
Antithrombotic Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation: Findings From the CONNECT AF+PCI Study.
Valle FH, Goodman SG, Tan M, Ha A, Mansour S, Welsh RC, Yan AT, Bainey KR, Rinfret S, Potter BJ, Khan R, Simkus G, Natarajan MK, Schwalm JD, Daneault B, Eisenberg MJ, Abunassar J, Har B, Gregoire J, Tanguay JF, Overgaard CB, Dery JP, De Larochelliere R, Paradis JM, Madan M, Elbarouni B, So DYF, Quraishi AU, Bagai A; CONNECT AF+PCI Study Investigators. Valle FH, et al. Among authors: madan m. CJC Open. 2021 Jul 6;3(12):1419-1427. doi: 10.1016/j.cjco.2021.07.003. eCollection 2021 Dec. CJC Open. 2021. PMID: 34993453 Free PMC article.
Provision of a DAPT Score to Cardiologists and Extension of Dual Antiplatelet Therapy Beyond 1 Year After ACS: Randomized Substudy of the Prospective Canadian ACS Reflective II Study.
Arbel Y, Patel AD, Goodman SG, Tan MK, Suskin N, McKelvie RS, Mathew AL, Ahmed F, Lutchmedial S, Dehghani P, Lavoie AJ, Huynh T, Lavi S, Khan R, Yan AT, Fordyce CB, Heffernan M, Jedrzkiewicz S, Madan M, Ahmed S, Barry C, Dery JP, Bagai A. Arbel Y, et al. Among authors: madan m. CJC Open. 2021 Jul 23;3(12):1463-1470. doi: 10.1016/j.cjco.2021.07.013. eCollection 2021 Dec. CJC Open. 2021. PMID: 34993458 Free PMC article.
357 results